143 related articles for article (PubMed ID: 12656667)
1. Major hyperestrogenism in a feminizing adrenocortical adenoma despite a moderate overexpression of the aromatase enzyme.
Bouraïma H; Lireux B; Mittre H; Benhaim A; Herrou M; Mahoudeau J; Guillon-Metz F; Kottler ML; Reznik Y
Eur J Endocrinol; 2003 Apr; 148(4):457-61. PubMed ID: 12656667
[TBL] [Abstract][Full Text] [Related]
2. Cosecretion of estrogen and inhibin B by a feminizing adrenocortical adenoma: impact on gonadotropin secretion.
Kuhn JM; Lefebvre H; Duparc C; Pellerin A; Luton JP; Strauch G
J Clin Endocrinol Metab; 2002 May; 87(5):2367-75. PubMed ID: 11994389
[TBL] [Abstract][Full Text] [Related]
3. Aromatase expression in a feminizing adrenocortical tumor.
Young J; Bulun SE; Agarwal V; Couzinet B; Mendelson CR; Simpson ER; Schaison G
J Clin Endocrinol Metab; 1996 Sep; 81(9):3173-6. PubMed ID: 8784064
[No Abstract] [Full Text] [Related]
4. Aromatase p450 expression in a feminizing adrenal adenoma presenting as isosexual precocious puberty.
Phornphutkul C; Okubo T; Wu K; Harel Z; Tracy TF; Pinar H; Chen S; Gruppuso PA; Goodwin G
J Clin Endocrinol Metab; 2001 Feb; 86(2):649-52. PubMed ID: 11158024
[TBL] [Abstract][Full Text] [Related]
5. Aromatase expression in the normal human adult adrenal and in adrenocortical tumors: biochemical, immunohistochemical, and molecular studies.
Moreau F; Mittre H; Benhaim A; Bois C; Bertherat J; Carreau S; Reznik Y
Eur J Endocrinol; 2009 Jan; 160(1):93-9. PubMed ID: 18974231
[TBL] [Abstract][Full Text] [Related]
6. Adult-onset hypogonadotropic hypogonadism caused by aberrant expression of aromatase in an adrenocortical adenocarcinoma.
Advani A; Johnson SJ; Nicol MR; Papacleovoulou G; Evans DB; Vaikkakara S; Mason JI; Quinton R
Endocr J; 2010; 57(7):651-6. PubMed ID: 20467160
[TBL] [Abstract][Full Text] [Related]
7. Feminizing Adrenocortical Carcinoma with Distinct Histopathological Findings.
Hatano M; Takenaka Y; Inoue I; Homma K; Hasegawa T; Sasano H; Awata T; Katayama S
Intern Med; 2016; 55(22):3301-3307. PubMed ID: 27853073
[TBL] [Abstract][Full Text] [Related]
8. Feminization as a result of both peripheral conversion of androgens and direct estrogen production from an adrenocortical carcinoma.
Zayed A; Stock JL; Liepman MK; Wollin M; Longcope C
J Endocrinol Invest; 1994 Apr; 17(4):275-8. PubMed ID: 7930380
[TBL] [Abstract][Full Text] [Related]
9. Estrogen secreting adrenal adenocarcinoma in an 18-month-old boy: aromatase activity, protein expression, mRNA and utilization of gonadal type promoter.
Watanabe T; Yasuda T; Noda H; Wada K; Kazukawa I; Someya T; Minamitani K; Minagawa M; Wataki K; Matsunaga T; Ohnuma N; Kohno Y; Harada N
Endocr J; 2000 Dec; 47(6):723-30. PubMed ID: 11228047
[TBL] [Abstract][Full Text] [Related]
10. Feminizing adrenocortical carcinoma in man.
Nishiki M; Amano K; Itoh H; Ezaki H; Miyachi Y
Jpn J Surg; 1980 Jun; 10(2):159-63. PubMed ID: 7431691
[TBL] [Abstract][Full Text] [Related]
11. Feminizing adrenocortical tumors in male patients: adenoma versus carcinoma.
Desai MB; Kapadia SN
J Urol; 1988 Jan; 139(1):101-3. PubMed ID: 3336072
[TBL] [Abstract][Full Text] [Related]
12. [Gynecomasty as a first sign of adrenal carcinoma--case report].
Czajka I; Zgliczyński W; Kasperlik-Załuska A; Cichocki A
Endokrynol Pol; 2005; 56(6):940-4. PubMed ID: 16821215
[TBL] [Abstract][Full Text] [Related]
13. Oestrogen producing adrenocortical adenoma: clinical, biochemical and immunohistochemical studies.
Goto T; Murakami O; Sato F; Haraguchi M; Yokoyama K; Sasano H
Clin Endocrinol (Oxf); 1996 Nov; 45(5):643-8. PubMed ID: 8977764
[TBL] [Abstract][Full Text] [Related]
14. Bilateral adrenocortical adenomas causing ACTH-independent Cushing's syndrome at different periods: a case report and discussion of corticosteroid replacement therapy following bilateral adrenalectomy.
Tung SC; Wang PW; Huang TL; Lee WC; Chen WJ
J Endocrinol Invest; 2004 Apr; 27(4):375-9. PubMed ID: 15233560
[TBL] [Abstract][Full Text] [Related]
15. Molecular basis of severe gynecomastia associated with aromatase expression in a fibrolamellar hepatocellular carcinoma.
Agarwal VR; Takayama K; Van Wyk JJ; Sasano H; Simpson ER; Bulun SE
J Clin Endocrinol Metab; 1998 May; 83(5):1797-800. PubMed ID: 9589695
[TBL] [Abstract][Full Text] [Related]
16. Feminizing adrenal neoplasms: case presentations and review of the literature.
Kidd MT; Karlin NJ; Cook CB
J Clin Oncol; 2011 Feb; 29(6):e127-30. PubMed ID: 21115870
[No Abstract] [Full Text] [Related]
17. Feminizing adrenocortical carcinoma with Cushing's syndrome and pseudohyperparathyroidism.
deAsis DN; Samaan NA
Arch Intern Med; 1978 Feb; 138(2):301-3. PubMed ID: 626558
[TBL] [Abstract][Full Text] [Related]
18. Expression of aromatase and estrogen receptors in human adrenocortical tumors.
Barzon L; Masi G; Pacenti M; Trevisan M; Fallo F; Remo A; Martignoni G; Montanaro D; Pezzi V; Palù G
Virchows Arch; 2008 Feb; 452(2):181-91. PubMed ID: 18157729
[TBL] [Abstract][Full Text] [Related]
19. [A feminizing adrenal cortex adenoma with Cushing's syndrome which can be stimulated with HCG].
Breustedt HJ; Nolde S; Tamm J
Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1340-3. PubMed ID: 206048
[No Abstract] [Full Text] [Related]
20. Cushing's syndrome due to a gastric inhibitory polypeptide-dependent adrenal adenoma: insights into hormonal control of adrenocortical tumorigenesis.
Chabre O; Liakos P; Vivier J; Chaffanjon P; Labat-Moleur F; Martinie M; Bottari SP; Bachelot I; Chambaz EM; Defaye G; Feige JJ
J Clin Endocrinol Metab; 1998 Sep; 83(9):3134-43. PubMed ID: 9745416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
